Top neuroscientists say Biogen's experimental drug for Alzheimer's disease appears to have promise as clinical treatment that slows the disease's attack on the brain -- despite the drug's complicated backstory and conflicting data from two clinical trials. If approved by the FDA, it could become the first drug to attack the dementia-causing disease itself and not just its symptoms.

Sections:  u.s.   
Topics:  Maryland   
RELATED ARTICLES

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News